A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy | NeoGenomics Laboratories

Publication date

Sat, 11/11/2017 - 12:00

Year

Subtitle

Published in Seminars in Diagnostic Pathology, November 2017

External link

https://www.jcancer.org/v08p2554.htm